| Property | Value |
|---|---|
| Protein Name | Bridging Integrator 1 (BIN1) |
| Gene | BIN1 |
| UniProt ID | O00499 |
| Molecular Weight | ~65-70 kDa (isoform dependent) |
| Subcellular Localization | Plasma membrane, T-tubules, endocytic vesicles |
| Protein Family | BAR domain proteins (Amphiphysin family) |
| Diseases | Alzheimer’s Disease, Myotonic Dystrophy, Cardiomyopathy |
Overview
BIN1 (Bridging Integrator 1) is a BAR domain protein encoded by the BIN1 gene that plays critical roles in membrane remodeling, endocytosis, and intracellular trafficking1BIN1 modulates tau pathology in Alzheimer's diseaseOpen reference2BIN1 regulates tau pathology in vivoOpen reference. It has emerged as the second most significant genetic risk factor for late-onset Alzheimer’s disease after APOE, with robust associations with tau pathology and disease progression3Meta-analysis of genome-wide association studies in ADOpen reference4BIN1 induces Tau-dependent network hyperexcitabilityOpen reference.
Structure
BIN1 is a member of the BAR (Bin/Amphiphysin/Rvs) domain protein family with a modular architecture5BIN1 structure and functionOpen reference:
N-Terminal BAR Domain
-
Residues: 1-270 (approx.)
-
Function: Dimerization and membrane curvature sensing/generation
-
Structure: Forms curved homodimers that tubulate membranes
Central Regions
-
CLINT domain: Clathrin-binding region (residues ~300-400)
-
SH3 domain: Proline-rich motif interactions with proteins like dynamin
-
Proline-rich region: Multiple protein-protein interaction motifs
Isoform Diversity
BIN1 has over 10 alternatively spliced isoforms:
-
Muscle isoforms: Include exon 13 for T-tubule targeting
-
Neuronal isoforms: Brain-specific patterns
-
Isoform 1: Ubiquitously expressed, canonical form
Normal Physiological Function
Membrane Dynamics
BIN1 is essential for membrane remodeling6BAR domain proteins and membrane curvatureOpen reference:
-
Membrane curvature: Sensing and induction of curved membranes
-
Vesicle formation: Facilitates clathrin-mediated endocytosis
-
T-tubule organization: Critical for skeletal and cardiac muscle
Endocytic Function
BIN1 participates in vesicle trafficking:
-
Clathrin-coated vesicles: Facilitates vesicle scission
-
Dynamin recruitment: Interacts with dynamin for fission
-
Actin regulation: Coordinates with actin cytoskeleton
Autophagy Regulation
BIN1 modulates autophagic processes:
-
Autophagosome formation: Regulates early stages of autophagy
-
Endosomal trafficking: Coordinates endosomal-autophagosomal pathways
-
Lysosomal function: Affects late stages of autophagy
Role in Alzheimer’s Disease
Genetic Association
GWAS have identified BIN1 as a major AD risk locus3Meta-analysis of genome-wide association studies in ADOpen reference7BIN1 genetic variants and AD riskOpen reference:
-
rs744373: Primary risk variant
-
Odds ratio: ~1.2-1.3 per risk allele
-
Population: Consistent across European and Asian ancestries
-
Mechanism: Expression quantitative trait loci (eQTL) effects
Pathophysiological Mechanisms
Tau Pathology
BIN1 is uniquely associated with tau pathology4BIN1 induces Tau-dependent network hyperexcitabilityOpen reference8Increased expression of BIN1 mediates AD genetic riskOpen reference:
-
Tau expression: Risk variants increase BIN1 expression
-
Tau propagation: BIN1 modulates tau spreading between neurons
-
Network hyperexcitability: BIN1-Tau interaction drives network dysfunction
Amyloid-Tau Interaction
BIN1 connects amyloid and tau pathologies:
-
Amyloid response: Modulates neuronal responses to Aβ
-
Synaptic dysfunction: BIN1 affects amyloid-induced synaptic deficits
-
Microglial modulation: Alters microglial response to pathology
Neuroinflammation
BIN1 modulates immune responses:
-
Microglial expression: Expressed in microglia near plaques
-
Cytokine regulation: Affects inflammatory cytokine production
-
TREM2 interaction: May work with other AD risk genes
Clinical Implications
-
Disease progression: BIN1 risk alleles predict faster progression
-
Biomarker potential: BIN1 levels in CSF may reflect pathology
-
Therapeutic target: Modulating BIN1 could affect tau spreading
Therapeutic Implications
Targeting BIN1
Therapeutic strategies are being explored2BIN1 regulates tau pathology in vivoOpen reference0:
-
Expression modulators: Reduce BIN1 overexpression
-
Interaction inhibitors: Block tau-BIN1 interaction
-
Splice-modifying therapies: Modulate isoform expression
Combination Approaches
BIN1-based therapies may combine with:
-
Anti-amyloid therapies
-
Anti-tau therapies
-
Microglial modulators
Key Publications
-
Chapman, J. et al. (2013) BIN1 and tau pathology in AD (Nature Neuroscience)
-
De Rossi, P. et al. (2020) BIN1 regulates tau pathology in vivo (Neuron)
-
Franzmeier, N. et al. (2020) BIN1 induces Tau-dependent network hyperexcitability (Brain)
-
Lambert, J.C. et al. (2013) Meta-analysis of AD GWAS (Nature Genetics)
Cross-References
-
BIN1 Gene — Gene encoding BIN1
-
Alzheimer’s Disease — Primary disease
-
Tau Protein — Interacting protein
-
Tau Pathology — Tau pathway
-
CLU/Clusterin — Another AD risk gene
-
Microglia — Brain immune cells
See Also
External Links
References
- BIN1 modulates tau pathology in Alzheimer's disease
- BIN1 regulates tau pathology in vivo
- Meta-analysis of genome-wide association studies in AD
- BIN1 induces Tau-dependent network hyperexcitability
- BIN1 structure and function
- BAR domain proteins and membrane curvature
- BIN1 genetic variants and AD risk
- Increased expression of BIN1 mediates AD genetic risk
- BIN1 in Alzheimer's disease
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.